Correlation Between Bank Central and PharmChem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank Central and PharmChem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Central and PharmChem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Central Asia and PharmChem, you can compare the effects of market volatilities on Bank Central and PharmChem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Central with a short position of PharmChem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Central and PharmChem.

Diversification Opportunities for Bank Central and PharmChem

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bank and PharmChem is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Bank Central Asia and PharmChem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmChem and Bank Central is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Central Asia are associated (or correlated) with PharmChem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmChem has no effect on the direction of Bank Central i.e., Bank Central and PharmChem go up and down completely randomly.

Pair Corralation between Bank Central and PharmChem

Assuming the 90 days horizon Bank Central Asia is expected to generate 0.58 times more return on investment than PharmChem. However, Bank Central Asia is 1.72 times less risky than PharmChem. It trades about -0.04 of its potential returns per unit of risk. PharmChem is currently generating about -0.08 per unit of risk. If you would invest  1,664  in Bank Central Asia on September 17, 2024 and sell it today you would lose (92.00) from holding Bank Central Asia or give up 5.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.44%
ValuesDaily Returns

Bank Central Asia  vs.  PharmChem

 Performance 
       Timeline  
Bank Central Asia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bank Central Asia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Bank Central is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
PharmChem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PharmChem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Bank Central and PharmChem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank Central and PharmChem

The main advantage of trading using opposite Bank Central and PharmChem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Central position performs unexpectedly, PharmChem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will offset losses from the drop in PharmChem's long position.
The idea behind Bank Central Asia and PharmChem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity